Droia Oncology Ventures raises second fund of EUR 150 million Droia Oncology Ventures raises second fund of EUR 150 million December 10th 2018: Droia, a specialist investor focused on oncology therapeutics, announced the closing of Droia II, its second fund, at...

Tusk Therapeutics to be acquired by Roche   Tusk Therapeutics to be acquired by Roche Stevenage, United Kingdom – September 28th 2018:  Tusk Therapeutics Ltd (“Tusk”) was today acquired by Roche. Tusk has developed an antibody with a novel...